Similar Articles |
|
IEEE Spectrum June 2012 Samuel K. Moore |
Electromagnetic Depression Treatment Nears Approval Deep transcranial magnetic stimulation adds to psychiatry's arsenal of electronic remedies |
IEEE Spectrum March 2006 Samuel K. Moore |
Psychiatry's Shocking New Tools Electronic implants and electromagnetic pulses are picking up where psychoactive drugs have failed. |
IEEE Spectrum May 2005 Samuel K. Moore |
Zapping Away The Blues Cyberonics Inc. plans to introduce the first implanted device that can treat a psychiatric illness. |
The Motley Fool February 4, 2005 Stephen D. Simpson |
Cyberonics' Depression Zapper Medical technology company gets a much-needed boost from the FDA. |
BusinessWeek May 2, 2005 Kate Murphy |
Easing Depression Without Drugs Doctors are trying therapies, from implants to herbs, that can cut down on side effects. |
The Motley Fool June 16, 2004 W.D. Crotty |
Nothing Depressing Cyberonics Cyberonics Gets FDA nod; shareholder Boston Scientific gets a portfolio boost. |
Fast Company April 2004 Scott Kirsner |
Fantastic Voyage Cyberonics' medical implant is the size of a chocolate-chip cookie, and it could be worth $2.8 billion someday. But as this dramatic tale of innovation and entrepreneurship shows, saving lives can be one tough business. |
Fast Company November 2004 Scott Kirsner |
A Slow, Patient Pace A follow-up to a recent story on a pacemaker that helps patients with epilepsy and seeks additional approval for patients who suffer from severe, drug-resistant depression -- including comments from the parents of a six-year-old epileptic who is using the device. |
The Motley Fool July 12, 2011 Arundhati Parmar |
FDA Allows Expansion of St. Jude Study to Treat Severe Depression St. Jude moves forward with treatment for depression. |
The Motley Fool December 31, 2010 Brian Orelli |
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. |
BusinessWeek March 7, 2005 Michael Arndt |
Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market. |
The Motley Fool February 8, 2005 Stephen D. Simpson |
Cyberonics Looks to the Future Shifting resources to the launch of a depression therapy will hurt now, but should pay off later. Investors looking to take on some risk in exchange for an aggressive growth opportunity might want to explore this one. |
The Motley Fool February 16, 2010 Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
American Family Physician January 1, 2006 Rupke, Blecke & Renfrow |
Cognitive Therapy for Depression Family physicians usually are the first to diagnose and treat patients with depression. They should inform patients that psychotherapy and pharmacotherapy are valid options, and that cognitive therapy is the most studied psychotherapy. |
Pharmaceutical Executive June 1, 2014 Jill Wechsler |
Compassionate Use Requests Complicate Drug Development Pharma, HCPs, and regulators walk tightrope in addressing early-access push while supporting biomedical R&D. |
Nursing April 2008 Kathryn Murphy |
Shedding the burden of depression & anxiety Learn about types of depression and available treatments. |
The Motley Fool November 22, 2005 Stephen D. Simpson |
Cyberonics' Ride Not Over Yet One way or another, this medical device maker's stock is almost certain to produce more volatility in the years to come. |
Pharmaceutical Executive December 1, 2013 |
FDA Pursues Delicate Balancing Act The Agency struggles to ensure access to needed medicines while minimizing potential risks, writes Jill Wechsler. |
Pharmaceutical Executive March 1, 2012 Ron Cohen |
FDA's Necessary Dose of Reality There's no fast-acting salve, but there are several steps that can be taken to streamline many of the procedures at FDA. And it begins with leadership. |
American Family Physician November 1, 2006 Lurie et al. |
Seasonal Affective Disorder Patients with seasonal affective disorder have episodes of major depression that tend to recur during specific times of the year, usually in winter. Like major depression, seasonal affective disorder probably is underdiagnosed in primary care settings. |
Wired July 24, 2007 Melinda Wenner |
A Few Transcranial Zaps and You're a Happy Genius A new technique called transcranial magnetic stimulation may let neuroscientists listen to the conversations between cells in your brain. |
The Motley Fool October 10, 2005 Stephen D. Simpson |
The FDA: Boon, Bane, Whipping Boy Everyone wants the FDA to be faster, better, and cheaper, but that may not be a credible expectation. Investors would do well to keep an eye on the FDA because its policies and pressures ultimately filter down to our medicine cabinets, wallets, and portfolios. |
Pharmaceutical Executive April 1, 2006 Jill Wechsler |
Washington Report: A Warning Trend Washington's new answer to drug safety concerns is more warnings and more disclosure of undigested data. But warnings can go too far. Haven't FDA's critics ever heard the story of the boy who cried wolf? |
IndustryWeek October 19, 2011 |
FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies? |
Pharmaceutical Executive June 1, 2007 Clinton & Wechsler |
The View From Inside Commissioner Andrew von Eschenbach on drug safety, DTC advertising, FDA's culture, and how the agency plans to bring itself into the age of molecular medicine. |
Pharmaceutical Executive December 1, 2006 Richard A. Epstein |
FDA vs. the Individual In this excerpt from his important new book Overdose, an ever controversial legal scholar argues that the current system overvalues risk, ignores individual differences, and deprives patients of valuable treatments. |
American Family Physician September 15, 2002 |
Depression What is depression?... What causes depression?... How is depression diagnosed?... How is depression treated?... What about suicide?... |